Zobrazeno 1 - 10
of 15
pro vyhledávání: '"M V, Jacobs"'
Publikováno v:
Obstetrics & Gynecology. 100:965-971
OBJECTIVE: To investigate the rate of clearance of human papillomavirus (HPV) infection after surgical treatment for cervical intraepithelial neoplasia (CIN). METHODS: One hundred nine women with CIN I–III, treated with cryosurgery or conization at
Autor:
D Zielinski, Feja J. Voorhorst, Petrus Josephus Ferdinandus Snijders, F A de Schipper, C. J. L. M. Meijer, René Pol, Arnold P Runsink, Jan M. M. Walboomers, M. V. Jacobs
Publikováno v:
British Journal of Cancer
The efficacy of four methods to recover DNA from Papanicolaou (Pap)-stained archival cervical smears for optimal detection of human papillomavirus (HPV) DNA by GP5+/bioGP6+ polymerase chain reaction (PCR) was investigated. Two of the methods were bas
Autor:
M. V. Jacobs, Peter J.F. Snijders, Feja J. Voorhorst, René H.M. Verheijen, Chris J.L.M. Meijer, Nathalie Fransen-Daalmeijer, Jan M. M. Walboomers
Publikováno v:
International Journal of Cancer. 87:221-227
Before guidelines can be set for the use of high-risk human papillomavirus (HR HPV) testing in cervical cancer screening and vaccine preparation, age-related prevalence of HR HPV types in cytologically normal smears has to be known. Therefore, in a c
Autor:
Herbert Pfister, Ingo Nindl, B. Johansson, Christophorus Joannes Lambertus Maria Meijer, A. Strand, Jan M. M. Walboomers, Ola Forslund, M. V. Jacobs, Göran Wadell, M. Von Knebel Doeberitz, Joakim Dillner, Feja J. Voorhorst, Petrus Josephus Ferdinandus Snijders, Thomas F. Meyer, Eggert Stockfleth
Publikováno v:
Journal of Clinical Pathology. 52:498-503
BACKGROUND: The development of a reproducible, sensitive, and standardised human papillomavirus (HPV) polymerase chain reaction (PCR) test is required to implement HPV testing in cervical cancer screening programmes and for triaging women with mild t
Autor:
Jan M. M. Walboomers, Franz X. Bosch, Keerti V. Shah, Chris J.L.M. Meijer, Nubia Muñoz, Julian Peto, M. V. Jacobs, M. M. Manos, J. A. Kummer, Peter J.F. Snijders
Publikováno v:
Journal of Pathology, 189, 12-19. John Wiley and Sons Ltd
Walboomers, J M M, Jacobs, M V, Manos, M M, Bosch, F X, Kummer, A, Shah, K V, Snijders, P J F, Peto, J & Meijer, C J L M 1999, ' Human papillomavirus in a necessary cause of invasive cervical cancer worldwide ', Journal of Pathology, vol. 189, pp. 12-19 . https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
Walboomers, J M M, Jacobs, M V, Manos, M M, Bosch, F X, Kummer, A, Shah, K V, Snijders, P J F, Peto, J & Meijer, C J L M 1999, ' Human papillomavirus in a necessary cause of invasive cervical cancer worldwide ', Journal of Pathology, vol. 189, pp. 12-19 . https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
A recent report that 93 per cent of invasive cervical cancers worldwide contain human papillomavirus (HPV) may be an underestimate, due to sample inadequacy or integration events affecting the HPV L1 gene, which is the target of the polymerase chain
Autor:
R.H.M. Verheijen, C. J. L. M. Meijer, Jan M. M. Walboomers, Feja J. Voorhorst, Petrus Josephus Ferdinandus Snijders, M. V. Jacobs, J.H.G.M. van Beek, Th.J.M. Helmerhorst, A. J. C. Van Den Brule
Publikováno v:
British Journal of Cancer
British Journal of Cancer, 81, 114-121. Nature Publishing Group
Jacobs, M V, Walboomers, J M M, van Beek, J, Voorhorst, F J, Verheijen, R H M, Meijer, C J L M, van den Brule, A J C, Helmerhorst, T J M & Snijders, P J F 1999, ' A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings ', British Journal of Cancer, vol. 81, pp. 114-121 . https://doi.org/10.1038/sj.bjc.6690659
British Journal of Cancer, 81, 114-121. Nature Publishing Group
Jacobs, M V, Walboomers, J M M, van Beek, J, Voorhorst, F J, Verheijen, R H M, Meijer, C J L M, van den Brule, A J C, Helmerhorst, T J M & Snijders, P J F 1999, ' A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings ', British Journal of Cancer, vol. 81, pp. 114-121 . https://doi.org/10.1038/sj.bjc.6690659
A quantitative polymerase chain reaction-enzyme immunoassay (Q-PCR-EIA) was developed to measure the amount of human papillomavirus (HPV) 16 DNA per genome equivalent in cervical scrapings. The quantitative approach was based on a combined competitiv
Autor:
P. Van Aarle, A. J. C. Van Den Brule, C. J. L. M. Meijer, J M Ossewaarde, P. Sillekens, B. Van Gemen, Servaas A. Morré, M. V. Jacobs, S. De Blok, J. M. M. Walboomers
Publikováno v:
Molecular Pathology. 51:149-154
AIM: To investigate the value of RNA detection by nucleic acid sequence based amplification (NASBA) for the monitoring of Chlamydia trachomatis infections after antibiotic treatment. METHODS: Cervical smears (n = 97) and urine specimens (n = 61) from
Autor:
M. V. Jacobs, Rolando Herrero, Jan M. M. Walboomers, F. Xavier Bosch, M. Santamaria, Virasakdi Chongsuvivatwong, Nubia Muñoz, Chris J.L.M. Meijer, Judith Deacon, Saibua Chichareon
Publikováno v:
JNCI: Journal of the National Cancer Institute. 90:50-57
Background Human papillomaviruses (HPV) types 16 and 18 are clearly involved in the etiology of cervical cancer, but the evidence for the carcinogenicity of other HPV types is limited. Cofactors involved in the progression from infection with HPV to
Autor:
Peter J.F. Snijders, Chris J.L.M. Meijer, A. J. C. Van Den Brule, Th.J.M. Helmerhorst, M. V. Jacobs, Jan M. M. Walboomers
Publikováno v:
Journal of Clinical Microbiology. 35:791-795
Two cocktails of digoxigenin-labeled human papillomavirus (HPV) type-specific oligonucleotide probes and an enzyme immunoassay (EIA) were used as a basis to developed a group-specific detection method for 14 high-risk (types 16, 18, 31, 33, 35, 39, 4
Autor:
J M, Walboomers, M V, Jacobs, M M, Manos, F X, Bosch, J A, Kummer, K V, Shah, P J, Snijders, J, Peto, C J, Meijer, N, Muñoz
Publikováno v:
The Journal of pathology. 189(1)
A recent report that 93 per cent of invasive cervical cancers worldwide contain human papillomavirus (HPV) may be an underestimate, due to sample inadequacy or integration events affecting the HPV L1 gene, which is the target of the polymerase chain